Stock Events

Stock Events

Jaguar Health 

$0.3129
309
-$0.01-1.88% 08:18 Today

Statistics

Day High
0.335
Day Low
0.298
52W High
85.4
52W Low
0.292
Volume
451,197
Avg. Volume
208,916
Mkt Cap
1.65M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-71.4
-49.29
-27.19
-5.08
Expected EPS
-40.95
Actual EPS
N/A

Financials

-465.42%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
11.51MRevenue
-53.58MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JAGX. It's not an investment recommendation.
NIO
38
NIO
Tesla
34
TSLA
Bionano Genomics
30
BNGO
Apple
29
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbvie
ABBV
Mkt Cap454.36B
AbbVie competes in the pharmaceutical sector, offering products that could rival Jaguar Health's gastrointestinal treatments.
Pfizer
PFE
Mkt Cap157.99B
Pfizer operates in various therapeutic areas, including treatments that could compete with Jaguar Health's offerings.
Johnson & Johnson
JNJ
Mkt Cap640.02B
Johnson & Johnson, through its pharmaceutical division, develops medications that could be in direct competition with Jaguar Health's products.
Merck
MRK
Mkt Cap355.1B
Merck is involved in the development of drugs that could potentially compete with Jaguar Health's gastrointestinal disease treatments.
Gilead Sciences
GILD
Mkt Cap178.21B
Gilead Sciences focuses on the discovery, development, and commercialization of medicines in areas potentially overlapping with Jaguar Health's market.
AMGEN
AMGN
Mkt Cap204.01B
Amgen, a biotech company, develops treatments that could compete with Jaguar Health's portfolio, especially in the gastrointestinal space.
Bristol-Myers Squibb
BMY
Mkt Cap130B
Bristol Myers Squibb offers a range of pharmaceutical products that could directly compete with Jaguar Health's treatments.
Novartis
NVS
Mkt Cap260.7B
Novartis provides healthcare solutions that could rival Jaguar Health's, including treatments for gastrointestinal diseases.
Sanofi
SNY
Mkt Cap102.48B
Sanofi operates globally in the pharmaceutical sector, with products that could compete with Jaguar Health's gastrointestinal treatments.
Astrazeneca
AZN
Mkt Cap248.41B
AstraZeneca is involved in the development and commercialization of pharmaceuticals that could directly compete with Jaguar Health's offerings in the gastrointestinal segment.

About

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Show more...
CEO
Lisa A. Conte
Employees
47
Country
United States
ISIN
US47010C8626
WKN
000A42ADK

Listings

MU
DE
1JA1.MU
MU
DE
1JA2.MU
STU
DE
1JA.STU
STU
DE
1JA1.STU

0 Comments

Share your thoughts

FAQ

What is Jaguar Health stock price today?▼
The current price of JAGX is $0.31 USD — it has decreased by -1.88% in the past 24 hours. Watch Jaguar Health stock price performance more closely on the chart.
What is Jaguar Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Jaguar Health stocks are traded under the ticker JAGX.
Is Jaguar Health stock price growing?▼
JAGX stock has fallen by -22.97% compared to the previous week, the month change is a -65.19% fall, over the last year Jaguar Health has showed a -99.54% decrease.
What is Jaguar Health market cap?▼
Today Jaguar Health has the market capitalization of 1.65M
When is the next Jaguar Health earnings date?▼
Jaguar Health is going to release the next earnings report on November 18, 2026.
What were Jaguar Health earnings last quarter?▼
JAGX earnings for the last quarter are -15.7 USD per share, whereas the estimation was -52.15 USD resulting in a +69.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Jaguar Health revenue for the last year?▼
Jaguar Health revenue for the last year amounts to 11.51M USD.
What is Jaguar Health net income for the last year?▼
JAGX net income for the last year is -53.58M USD.
How many employees does Jaguar Health have?▼
As of September 15, 2026, the company has 47 employees.
In which sector is Jaguar Health located?▼
Jaguar Health operates in the Health & Wellness sector.
When did Jaguar Health complete a stock split?▼
The last stock split for Jaguar Health was on April 30, 2026 with a ratio of 1:35.
Where is Jaguar Health headquartered?▼
Jaguar Health is headquartered in SAN FRANCISCO, United States.